InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) (FRA:MWG2)
TSX Ticker Symbol: IN
OTC Ticker Symbol: IMLFF
Frankfurt Ticker Symbol: MWG2

InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) (FRA:MWG2) is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology, and drug development pipeline are the fundamental drivers of shareholder value.

ZIP Code: V6C 1S4
Business Website Address:
Business Phone Number: 1-778-945-0960
Country: Canada